Data Science and Bioinformatics Services

In the rapidly evolving landscape of preclinical drug discovery, bioinformatics serves as an essential tool. Leveraging computational analysis and data-driven insights, it accelerates target identification, disease and drug mechanism of action (MoA) discovery, and biomarker discovery, reducing costs and late-stage risks. Crown Bioscience's in-house bioinformatics team excels in harnessing 'omics big data, unlocking innovation-driving insights. By leveraging bioinformatics, we maximize data value, enabling informed decisions, including biomarker-driven clinical trial design, derisking drug development, and offering cost savings. Our commitment to innovation drives us to bring promising drugs to the clinical stage, advancing healthcare and improving outcomes.